User menu

The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.

Bibliographic reference Noel, Laura ; Arts, Florence ; Montano Almendras, Carmen Patricia ; Cox, L ; Gielen, O ; et. al. The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.. In: Molecular Oncology, Vol. 8, no.3, p. 728-740 (2014)
Permanent URL http://hdl.handle.net/2078.1/145126
  1. Ali Samir, Nouhi Zaynab, Chughtai Naila, Ali Suhad, SHP-2 Regulates SOCS-1-mediated Janus Kinase-2 Ubiquitination/Degradation Downstream of the Prolactin Receptor, 10.1074/jbc.m306758200
  2. Andrae J., Gallini R., Betsholtz C., Role of platelet-derived growth factors in physiology and medicine, 10.1101/gad.1653708
  3. Araki Toshiyuki, Nawa Hiroyuki, Neel Benjamin G., Tyrosyl Phosphorylation of Shp2 Is Required for Normal ERK Activation in Response to Some, but Not All, Growth Factors, 10.1074/jbc.m306461200
  4. Bazenet, Mol. Cell Biol, 16, 6926 (1996)
  5. Bennett A. M., Tang T. L., Sugimoto S., Walsh C. T., Neel B. G., Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras., 10.1073/pnas.91.15.7335
  6. Buitenhuis M., Verhagen L. P., Cools J., Coffer P. J., Molecular Mechanisms Underlying FIP1L1-PDGFRA-Mediated Myeloproliferation, 10.1158/0008-5472.can-06-4183
  7. Chan Gordon, Kalaitzidis Demetrios, Neel Benjamin G., The tyrosine phosphatase Shp2 (PTPN11) in cancer, 10.1007/s10555-008-9126-y
  8. Chen Jing, Yu Wen-Mei, Bunting Kevin D, Qu Cheng-Kui, A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival, 10.1038/sj.onc.1207471
  9. Chen Yuhong, Wen Renren, Yang Shoua, Schuman James, Zhang Eric E., Yi Taolin, Feng Gen-Sheng, Wang Demin, Identification of Shp-2 as a Stat5A Phosphatase, 10.1074/jbc.m210572200
  10. Cools Jan, DeAngelo Daniel J., Gotlib Jason, Stover Elizabeth H., Legare Robert D., Cortes Jorges, Kutok Jeffrey, Clark Jennifer, Galinsky Ilene, Griffin James D., Cross Nicholas C.P., Tefferi Ayalew, Malone James, Alam Rafeul, Schrier Stanley L., Schmid Janet, Rose Michal, Vandenberghe Peter, Verhoef Gregor, Boogaerts Marc, Wlodarska Iwona, Kantarjian Hagop, Marynen Peter, Coutre Steven E., Stone Richard, Gilliland D. Gary, A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome, 10.1056/nejmoa025217
  11. Cools Jan, Stover Elizabeth H, Boulton Christina L, Gotlib Jason, Legare Robert D, Amaral Sonia M, Curley David P, Duclos Nicole, Rowan Rebecca, Kutok Jeffery L, Lee Benjamin H, Williams Ifor R, Coutre Steven E, Stone Richard M, DeAngelo Daniel J, Marynen Peter, Manley Paul W, Meyer Thomas, Fabbro Doriano, Neuberg Donna, Weisberg Ellen, Griffin James D, Gilliland D.Gary, PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease, 10.1016/s1535-6108(03)00108-9
  12. Corless Christopher L., Schroeder Arin, Griffith Diana, Town Ajia, McGreevey Laura, Harrell Patina, Shiraga Sharon, Bainbridge Troy, Morich Jason, Heinrich Michael C., PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib, 10.1200/jco.2005.14.068
  13. Dance Marie, Montagner Alexandra, Salles Jean-Pierre, Yart Armelle, Raynal Patrick, The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway, 10.1016/j.cellsig.2007.10.002
  14. Demoulin, Cancer Res., 60, 3971 (2000)
  15. Dewaele B., Wasag B., Cools J., Sciot R., Prenen H., Vandenberghe P., Wozniak A., Schoffski P., Marynen P., Debiec-Rychter M., Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal Stromal Tumor-Associated PDGFRAD842V Mutation, 10.1158/1078-0432.ccr-08-0533
  16. Elling C., Erben P., Walz C., Frickenhaus M., Schemionek M., Stehling M., Serve H., Cross N. C. P., Hochhaus A., Hofmann W.-K., Berdel W. E., Muller-Tidow C., Reiter A., Koschmieder S., Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease, 10.1182/blood-2010-05-286757
  17. Fambrough Douglas, McClure Kimberly, Kazlauskas Andrius, Lander Eric S, Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes, 10.1016/s0092-8674(00)80785-0
  18. Gleich Gerald J, Leiferman Kristin M, Pardanani Animesh, Tefferi Ayalew, Butterfield Joseph H, Treatment of hypereosinophilic syndrome with imatinib mesilate, 10.1016/s0140-6736(02)08505-7
  19. Goss V. L., A common phosphotyrosine signature for the Bcr-Abl kinase, 10.1182/blood-2005-08-3399
  20. Heinrich M. C., PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors, 10.1126/science.1079666
  21. Heldin, Biochim. Biophys. Acta, 1378, F79 (1998)
  22. Huss Sebastian, Wardelmann Eva, Goltz Diane, Binot Elke, Hartmann Wolfgang, Merkelbach-Bruse Sabine, Büttner Reinhard, Schildhaus Hans-Ulrich, Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization : PDGFRA mutations in IFP, 10.1111/j.1365-2559.2012.04203.x
  23. Kallin Anders, Demoulin Jean-Baptiste, Nishida Keigo, Hirano Toshio, Rönnstrand Lars, Heldin Carl-Henrik, Gab1 Contributes to Cytoskeletal Reorganization and Chemotaxis in Response to Platelet-derived Growth Factor, 10.1074/jbc.m312996200
  24. Leevers, Embo J., 11, 569 (1992)
  25. Leischner H., Albers C., Grundler R., Razumovskaya E., Spiekermann K., Bohlander S., Ronnstrand L., Gotze K., Peschel C., Duyster J., SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML, 10.1182/blood-2011-07-365726
  26. Lierman E, Michaux L, Beullens E, Pierre P, Marynen P, Cools J, Vandenberghe P, FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib, 10.1038/leu.2009.2
  27. Liu, J. Signal Transduction, 2011, 195239 (2011)
  28. Louahed, Blood, 94, 1701 (1999)
  29. Lu Wei, Gong Delquin, Bar-Sagi Dafna, Cole Philip A, Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell Signaling, 10.1016/s1097-2765(01)00369-0
  30. Mali R. S., Ma P., Zeng L.-F., Martin H., Ramdas B., He Y., Sims E., Nabinger S., Ghosh J., Sharma N., Munugalavadla V., Chatterjee A., Li S., Sandusky G., Craig A. W., Bunting K. D., Feng G.-S., Chan R. J., Zhang Z.-Y., Kapur R., Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT, 10.1182/blood-2011-08-375873
  31. Martinelli Simone, Torreri Paola, Tinti Michele, Stella Lorenzo, Bocchinfuso Gianfranco, Flex Elisabetta, Grottesi Alessandro, Ceccarini Marina, Palleschi Antonio, Cesareni Gianni, Castagnoli Luisa, Petrucci Tamara C., Gelb Bruce D., Tartaglia Marco, Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes, 10.1093/hmg/ddn099
  32. Medves S, Duhoux F P, Ferrant A, Toffalini F, Ameye G, Libouton J-M, Poirel H A, Demoulin J-B, KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia, 10.1038/leu.2010.13
  33. Medves S., Noel L. A., Montano-Almendras C. P., Albu R. I., Schoemans H., Constantinescu S. N., Demoulin J.-B., Multiple oligomerization domains of KANK1-PDGFR  are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK, 10.3324/haematol.2011.040147
  34. Metzgeroth Georgia, Walz Christoph, Erben Philipp, Popp Helena, Schmitt-Graeff Annette, Haferlach Claudia, Fabarius Alice, Schnittger Susanne, Grimwade David, Cross Nicholas C. P., Hehlmann Rüdiger, Hochhaus Andreas, Reiter Andreas, Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study, 10.1111/j.1365-2141.2008.07294.x
  35. Miyake Sachiko, Mullane-Robinson Karen P., Lill Nancy L., Douillard Patrice, Band Hamid, Cbl-mediated Negative Regulation of Platelet-derived Growth Factor Receptor-dependent Cell Proliferation : A CRITICAL ROLE FOR Cbl TYROSINE KINASE-BINDING DOMAIN, 10.1074/jbc.274.23.16619
  36. Montano-Almendras C. P., Essaghir A., Schoemans H., Varis I., Noel L. A., Velghe A. I., Latinne D., Knoops L., Demoulin J.-B., ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor- B, 10.3324/haematol.2011.047530
  37. Mulligan G., Lichter D. I., Di Bacco A., Blakemore S. J., Berger A., Koenig E., Bernard H., Trepicchio W., Li B., Neuwirth R., Chattopadhyay N., Bolen J. B., Dorner A. J., van de Velde H., Ricci D., Jagannath S., Berenson J. R., Richardson P. G., Stadtmauer E. A., Orlowski R. Z., Lonial S., Anderson K. C., Sonneveld P., San Miguel J. F., Esseltine D.-L., Schu M., Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy, 10.1182/blood-2013-05-504340
  38. Nabinger S C, Li X J, Ramdas B, He Y, Zhang X, Zeng L, Richine B, Bowling J D, Fukuda S, Goenka S, Liu Z, Feng G-S, Yu M, Sandusky G E, Boswell H S, Zhang Z-Y, Kapur R, Chan R J, The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo, 10.1038/leu.2012.308
  39. Neel Benjamin G., Gu Haihua, Pao Lily, The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling, 10.1016/s0968-0004(03)00091-4
  40. Pluskey Scott, Wandless Thomas J., Walsh Christopher T., Shoelson Steven E., Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains, 10.1074/jbc.270.7.2897
  41. Reddi Alagarsamy Lakku, Ying GuoGuang, Duan Lei, Chen Gengsheng, Dimri Manjari, Douillard Patrice, Druker Brian J., Naramura Mayumi, Band Vimla, Band Hamid, Binding of Cbl to a Phospholipase Cγ1-docking Site on Platelet-derived Growth Factor Receptor β Provides a Dual Mechanism of Negative Regulation, 10.1074/jbc.m701797200
  42. Rönnstrand Lars, Arvidsson Ann-Kristin, Kallin Anders, Rorsman Charlotte, Hellman Ulf, Engström Ulla, Wernstedt Christer, Heldin Carl-Henrik, SHP-2 binds to Tyr763 and Tyr1009 in the PDGF β-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis, 10.1038/sj.onc.1202705
  43. Rupp Eva, Siegbahn Agneta, Ronnstrand Lars, Wernstedt Christer, Claesson-Welsh Lena, Heldin Carl-Henrik, A Unique Autophosphorylation Site in the Platelet-Derived Growth Factor alpha Receptor from a Heterodimeric Receptor Complex, 10.1111/j.1432-1033.1994.00029.x
  44. Schwaller Juerg, Frantsve Julie, Aster Jon, Williams Ifor R., Tomasson Michael H., Ross Theodora S., Peeters Pieter, Van Rompaey Luc, Van Etten Richard A., Ilaria Robert, Marynen Peter, Gilliland D.Gary, Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes, 10.1093/emboj/17.18.5321
  45. Stover E. H., Chen J., Folens C., Lee B. H., Mentens N., Marynen P., Williams I. R., Gilliland D. G., Cools J., Activation of FIP1L1-PDGFR  requires disruption of the juxtamembrane domain of PDGFR  and is FIP1L1-independent, 10.1073/pnas.0601192103
  46. Sun Jianmin, Pedersen Malin, Rönnstrand Lars, The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction, 10.1074/jbc.m808058200
  47. Sweeney Michael C., Wavreille Anne-Sophie, Park Junguk, Butchar Jonathan P., Tridandapani Susheela, Pei Dehua, Decoding Protein−Protein Interactions through Combinatorial Chemistry:  Sequence Specificity of SHP-1, SHP-2, and SHIP SH2 Domains†, 10.1021/bi051408h
  48. Tallquist Michelle D, French Wendy J, Soriano Philippe, Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell Development, 10.1371/journal.pbio.0000052
  49. Toffalini F., Demoulin J.-B., New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases, 10.1182/blood-2010-04-279752
  50. Toffalini Federica, Hellberg Carina, Demoulin Jean-Baptiste, Critical Role of the Platelet-derived Growth Factor Receptor (PDGFR) β Transmembrane Domain in the TEL-PDGFRβ Cytosolic Oncoprotein, 10.1074/jbc.m109.076638
  51. Toffalini F., Kallin A., Vandenberghe P., Pierre P., Michaux L., Cools J., Demoulin J.-B., The fusion proteins TEL-PDGFR  and FIP1L1-PDGFR  escape ubiquitination and degradation, 10.3324/haematol.2008.001149
  52. Tomasson Michael H., Sternberg David W., Williams Ifor R., Carroll Martin, Cain Danielle, Aster Jon C., Ilaria Robert L., Etten Richard A. Van, Gilliland D. Gary, Fatal myeloproliferation, induced in mice by TEL/PDGFβR expression, depends on PDGFβR tyrosines 579/581, 10.1172/jci8902
  53. Valgeirsdóttir Sigrídur, Paukku Kirsi, Silvennoinen Olli, Heldin Carl-Henrik, Claesson-Welsh Lena, Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF β-receptor juxtamembrane and kinase insert domains, 10.1038/sj.onc.1201555
  54. Vardiman J. W., Thiele J., Arber D. A., Brunning R. D., Borowitz M. J., Porwit A., Harris N. L., Le Beau M. M., Hellstrom-Lindberg E., Tefferi A., Bloomfield C. D., The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, 10.1182/blood-2009-03-209262
  55. Velghe A I, Van Cauwenberghe S, Polyansky A A, Chand D, Montano-Almendras C P, Charni S, Hallberg B, Essaghir A, Demoulin J-B, PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations, 10.1038/onc.2013.218
  56. Walter Annette O, Peng Zao-Yuan, Cartwright Christine A, The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism, 10.1038/sj.onc.1202513
  57. Xu Dan, Protein tyrosine phosphatases in the JAK/STAT pathway, 10.2741/3051
  58. Zhang Si Qing, Yang Wentian, Kontaridis Maria I., Bivona Trever G., Wen Gengyun, Araki Toshiyuki, Luo Jincai, Thompson Julie A., Schraven Burkhart L., Philips Mark R., Neel Benjamin G., Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment, 10.1016/s1097-2765(04)00050-4